维生素中国E-新闻(维生素中国电子新闻202211)

In Nov., the vitamin market in China was stable but relatively sluggish. The attention on vitamin A, vitamin E, and vitamin C heightened. Due to concerns arising from energy difficulties in Europe, the producers of related vitamin varieties in China, inclined to keep the price from falling, stopped giving price quotations or raised their quotation prices.

As of late Oct., 14 listed vitamin companies have released their performance reports for Q3 2022. Among those 14 companies, there are three companies that delivered year-on-year increases in their operating revenue and net profit attributable to equity holders for Q1–Q3 of 2022, which include two companies that produce vitamin K3, namely Brother Enterprises Holdings Co., Ltd. and Hubei Zhenhua Chemical Co., Ltd.

News about several projects has been reported: Shandong Hwatson Biochem Co., Ltd.'s vitamin base project (Phase I); Nanjing Haijing Pharmaceutical Co., Ltd.'s "upgrading and renovation project"; Jiangxi Nuowei Biotechnology Co., Ltd.'s "lanolin comprehensive utilisation project"; Jiangsu Brother Vitamins Co., Ltd.'s "upgrading and renovation project for environmental safety rectification"; Rionlon (Tianjin) Pharmaceutical Co., Ltd.'s "vitamin K2 API preparation and relevant intermediates project" Xinfa Pharmaceutical Co., Ltd.'s "project of upgrading and integrating industrial chain for vitamin nutritional supplements"; Zhejiang Shengda Bio-pharm Co., Ltd.'s "project of production lines for vitamin B6, perindopril active pharmaceutical ingredient (API) and other APIs".

The European Food Safety Authority (EFSA) issued a scientific opinion on the characterisation and safety of vitamin B2/riboflavin produced by fermentation with a genetically modified strain of Bacillus subtilis (KCCM 10445) as a nutritional additive in feed and water for drinking for all animal species. The EFSA Panel on Additives and Products or Substances used in Animal Feed concludes that the use of vitamin B2/riboflavin produced by B. subtilis (KCCM 10445) is safe for the target species, the consumer and the environment.

The USD/RMB exchange rate in this Report is USD1.00=CNY7.2081 on 1 Nov., 2022, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.